Tuesday Thirteen Inc. 4
4 · Mirati Therapeutics, Inc. · Filed Nov 22, 2017
Insider Transaction Report
Form 4
Tuesday Thirteen Inc.
10% Owner
Transactions
- Sale
Common Stock
2017-09-21$10.65/sh−1,000$10,650→ 0 total
Footnotes (1)
- [F1]These securities are owned directly by the reporting person, who may be deemed to be a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, LLC ("Boxer Capital"), (ii) Boxer Asset Management Inc. ("Boxer Management"), (iii) MVA Investors, LLC, (iv) Braslyn Ltd., (v) the reporting person, (vi) Joseph C. Lewis, (vii) Christopher Fuglesang, (viii) Rodney W. Lappe, (ix) Ivan M. Lieberburg, (x) Aaron I. Davis, (xi) Neil Reisman and (xii) Shehan B. Dissanayake. Joseph C. Lewis is the sole indirect beneficial owner of and controls Tuesday Thirteen Inc.